GlycoMimetics to Present at Upcoming Investor Conferences

On April 4, 2019 GlycoMimetics, Inc. (Nasdaq: GLYC) reported that senior management will present corporate updates at two upcoming investor conferences in April (Press release, GlycoMimetics, APR 4, 2019, View Source [SID1234535009]). Details are as follows:

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

HC WAINWRIGHT GLOBAL LIFE SCIENCES CONFERENCE
Who: Chief Financial Officer Brian Hahn
When: Tuesday, April 9 at 2:10 p.m. (GMT)
Where: London, UK

18TH ANNUAL NEEDHAM HEALTHCARE CONFERENCE
Who: Chief Executive Officer Rachel King
When: Wednesday, April 10 at 3:30 p.m. (ET)
Where: New York, NY

To access the live webcast and subsequent archived recordings for each of these presentations, please visit the GlycoMimetics website at www.glycomimetics.com.